AI - assisted drug discovery held back by private sector secrecy on datasets
Scientists have warned that artificial intelligence (AI) could hamper efforts to develop new drugs in the fight against a lack of access to genetically modified molecules, according to the OECD-backed investigation into the issue.
Source: sciencebusiness.netPublished on 2021-12-14
Related news
- A Dumpling vs Wall St : Why we need synthetics .
- A Dumpling vs Wall St : Why we need synthetics .
- A Dumpling vs Wall St : Why we need synthetics .
- A New Approach to Digital Public Goods Is Gaining Steam
- 12 ways DITO enhances Pinoy digital lifestyles
- A new coronavirus vaccine heading to India was developed by a small team in Texas . It expects nothing in return .
- What is open data and why it important for your business ?
- New data - sharing requirements from the National Institutes of Health are a big step toward more open science and potentially higher - quality research
- Report of the Independent Panel for Pandemic Preparedness and Response : making COVID - 19 the last pandemic
- Here The Lowdown On That Kick - Arse 2 . 5D Cyberpunk Game
- It a snap : City Nature Challenge is a friendly competition to help scientists collect wildlife data
- SubQuery Expands Data Indexing to Terra
- Genomic data for biodiversity global challenge
- The West is ill - prepared to deal with evolving cyber threats , report concludes
- Bloomberg Philanthropies Commits $25 Million To Accelerate Satellite & Airborne Methane Sensing Technologies To Turbocharge Fight Against Climate Change